China Pharma Holdings, Inc.
CPHI
$1.75
-$0.035-1.97%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.57M | -4.74M | -4.74M | -4.40M | -3.56M |
| Total Depreciation and Amortization | 2.21M | 2.62M | 2.87M | 2.85M | 2.81M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 670.60K | 582.70K | 595.30K | 547.50K | 155.90K |
| Change in Net Operating Assets | 1.74M | 1.07M | 555.80K | 1.33M | 778.60K |
| Cash from Operations | 61.00K | -466.40K | -727.20K | 327.10K | 183.40K |
| Capital Expenditure | -96.70K | -38.40K | -23.40K | -39.60K | -67.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -60.50K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -275.90K | -253.30K | -- | -- | -- |
| Cash from Investing | -372.80K | -291.80K | -23.40K | -100.10K | -67.50K |
| Total Debt Issued | 513.20K | 513.20K | 1.57M | 1.54M | 1.05M |
| Total Debt Repaid | -569.60K | -492.80K | -1.53M | -1.98M | -1.49M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.80K | 6.90K | 6.90K | 6.90K | 6.90K |
| Cash from Financing | -49.50K | 27.40K | 51.00K | -432.20K | -438.20K |
| Foreign Exchange rate Adjustments | -65.00K | -66.30K | 48.30K | 42.60K | -5.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -426.10K | -796.90K | -651.10K | -162.50K | -328.00K |